Literature DB >> 29178103

[Influence of CCL21 on the invasion and metastasis of colorectal cancer].

Yuming Rong1, Xi Chen2, Dejun Fan3, Xutao Lin3, Xiaobin Zheng2, Chi Zhou2, Tuo Hu2, Yifeng Zou4.   

Abstract

OBJECTIVE: To investigate the influence of CCL21 on the invasion and metastasis of colorectal cancer (CRC).
METHODS: CCL21 over-expressing CRC cell line was constructed by lentivirus infection and CCL21 low-expressing CRC cell line was constructed by lipofection. The effects of CCL21 on the invasion and metastasis of CRC cells and the stem cell-like phenotype were investigated by Transwell migration, invasion assay, wound healing assay and sphere formation assay.
RESULTS: Real-time quantitative PCR and western blot confirmed that the expression of CCL21 was up-regulated by lentiviral transfection and down-regulated by siRNA liposome transfection. In vitro, Transwell assays showed that the invasion and migration in CCL21 over-expressing CRC cells decreased significantly as compared to those of CCL21 low-expressing cells. In wound healing assay, the CCL21 over-expressing CRC cells showed a significantly lower rate of migration. In addition, the sphere formation rate and density of CCL21 over-expressing CRC cells were lower than those with low-expression of CCL21.
CONCLUSION: CCL21 can suppress the migration and invasion of CRC cells and weaken their stem cell-like phenotype.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29178103

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

1.  Comprehensive analysis of m6A circRNAs identified in colorectal cancer by MeRIP sequencing.

Authors:  Feng He; Qin Guo; Guo-Xiu Jiang; Yan Zhou
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

2.  Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.

Authors:  Bowen Chen; Shuyuan Zhang; Qiuyu Li; Shiting Wu; Han He; Jinbo Huang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.